Tesaglitazar (AZ 242)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tesaglitazar (AZ 242), covering 2006-07-31 to 2006-07-31. Get the full timeline:
Most recent: Clinical Trial Update: GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes [Phase 2]